Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML)

Historical Holders from Q4 2023 to Q3 2025

Symbol: TRML
Type / Class: Equity / Common stock, par value $0.0001 per share
Shares outstanding: 25,669,673
All holders as of 30 Sep 2025: Q3 2025
Total 13F shares, excl. options: 21,619,638
Holdings value: $1,034,071,326
% of all portfolios: 0%
Number of holders: 134
Number of buys: 73
Number of sells: -70
Average buys %: +0%
Average sells %: -0%

Reported Shares, Excluding Options vs Price

Reported Value, Excluding Options

Total Investors

Significant Owners of Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML)

Filer	Ownership	Change %	Holdings Value	Net Change	Nb Shares	Change %	Reporting Name	Report Period
Avoro Capital Advisors LLC	9.95%		$41,374,435		2,555,555		Avoro Capital Advisors LLC	30 Jun 2025
QVT Financial LP	8.39%	+44.2%	$34,883,832	+$11,029,988	2,154,653	+46.2%	QVT Financial LP	30 Jun 2025
BlackRock, Inc.	5.5%		$67,527,642		1,411,832		BlackRock, Inc.	30 Sep 2025
Blue Owl Capital Holdings LP	4.2%		$18,693,840		1,079,321		Blue Owl Capital Holdings LP	31 Dec 2024

Institutional Holders of Tourmaline Bio, Inc. - Common stock, par value $0.0001 per share (TRML)

Period	Reported Shares, Excl. Options	Value, Excl. Options	Value Change	Puts Notional Value	Calls Notional Value	Price	Investors
2025 Q3	21,619,638	$1,034,071,326	+$121,177,979	$3,697,259	$1,425,334	$47.83	134
2025 Q2	24,065,900	$384,816,806	+$2,889,804	$0	$0	$15.99	107
2025 Q1	23,949,691	$364,277,074	+$11,366,358	$89,739	$3,075,462	$15.21	107
2024 Q4	22,862,128	$463,645,747	+$8,433,550	$241,332	$87,204	$20.28	100
2024 Q3	21,032,430	$540,747,034	+$2,114,469	$231,390	$251,958	$25.71	90
2024 Q2	21,154,139	$272,043,601	-$49,208,613	$798,606	$209,618	$12.86	83
2024 Q1	20,558,012	$469,902,038	+$169,395,770	$2,821,280	$10,730,940	$22.90	95
2023 Q4	13,012,529	$338,184,018	+$338,184,018			$26.18	54